Debating the Relevance of Resistin

Data derived from the Science Watch/Hot Papers database and the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average paper of the same type and age. Diabetes researchers have long known about the connection between obesity and insulin resistance, but they have yet to identify the hormonal machinery responsible for that connection. In this Hot Paper, published 18 months ago, investigators appeared to have uncovered a major part of that ma

Written byEugene Russo
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Diabetes researchers have long known about the connection between obesity and insulin resistance, but they have yet to identify the hormonal machinery responsible for that connection. In this Hot Paper, published 18 months ago, investigators appeared to have uncovered a major part of that machinery when they discovered the resistin hormone in mice.1 More recent findings, however, have cast doubt on resistin's relevance in human diabetes.

Senior author Mitchell Lazar, director of the University of Pennsylvania Diabetes Center, notes two major factors that helped lead his group to discover resistin. First, based on findings related to leptin, the now infamous hormonal fat-regulator, Lazar knew that fat not only serves to store energy, but also helps communicate with other tissues. Leptin, and other fat-secreted molecules, are proof that fat cells make unique signaling molecules that communicate with other parts of the body.

Second, the mechanism of action of one antidiabetic drug ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies